FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1424956443> ?p ?o ?g. }

• W1424956443 endingPage "615" @default.
• W1424956443 startingPage "610" @default.
• W1424956443 abstract "This study compared treatment outcomes of adult patients with bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae (ESBL-EK) receiving flomoxef versus those receiving a carbapenem as definitive therapy. In propensity score matching (PSM) analysis, case patients receiving flomoxef shown to be active in vitro against ESBL-EK were matched with controls who received a carbapenem. The primary endpoint was 30-day crude mortality. The flomoxef group had statistically significantly higher sepsis-related mortality (27.3% vs. 10.5%) and 30-day mortality (28.8% vs. 12.8%) than the carbapenem group. Of the bacteraemic episodes caused by isolates with a MICflomoxef of ≤1 mg/L, sepsis-related mortality rates were similar between the two treatment groups (8.7% vs. 6.4%; P = 0.73). The sepsis-related mortality rate of the flomoxef group increased to 29.6% and 50.0% of episodes caused by isolates with a MICflomoxef of 2–4 mg/L and 8 mg/L, respectively, which was significantly higher than the carbapenem group (12.3%). In the PSM analysis of 86 case–control pairs infected with strains with a MICflomoxef of 2–8 mg/L, case patients had a significantly higher 30-day mortality rate (38.4% vs. 18.6%). Multivariate regression analysis revealed that flomoxef therapy for isolates with a MICflomoxef of 2–8 mg/L, concurrent pneumonia or urosepsis, and a Pitt bacteraemia score ≥4 were independently associated with 30-day mortality. Definitive flomoxef therapy appears to be inferior to carbapenems in treating ESBL-EK bacteraemia, particularly for isolates with a MICflomoxef of 2–8 mg/L, even though the currently suggested MIC breakpoint of flomoxef is ≤8 mg/L." @default.
• W1424956443 created "2016-06-24" @default.
• W1424956443 creator A5013737084 @default.
• W1424956443 creator A5017288257 @default.
• W1424956443 creator A5032788800 @default.
• W1424956443 creator A5040170945 @default.
• W1424956443 creator A5041265388 @default.
• W1424956443 creator A5052266233 @default.
• W1424956443 creator A5069628333 @default.
• W1424956443 date "2015-12-01" @default.
• W1424956443 modified "2023-10-17" @default.
• W1424956443 title "Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospective study" @default.
• W1424956443 cites W1528292269 @default.
• W1424956443 cites W1853786629 @default.
• W1424956443 cites W1945945803 @default.
• W1424956443 cites W1973968673 @default.
• W1424956443 cites W2000445173 @default.
• W1424956443 cites W2032073780 @default.
• W1424956443 cites W2076322253 @default.
• W1424956443 cites W2093607447 @default.
• W1424956443 cites W2096445424 @default.
• W1424956443 cites W2103573127 @default.
• W1424956443 cites W2123634087 @default.
• W1424956443 cites W2124945254 @default.
• W1424956443 cites W2131946678 @default.
• W1424956443 cites W2133118972 @default.
• W1424956443 cites W2133973692 @default.
• W1424956443 cites W2151426785 @default.
• W1424956443 cites W2156473505 @default.
• W1424956443 cites W2158637043 @default.
• W1424956443 cites W2165111961 @default.
• W1424956443 cites W2168409658 @default.
• W1424956443 cites W2168719284 @default.
• W1424956443 cites W2168764308 @default.
• W1424956443 doi "https://doi.org/10.1016/j.ijantimicag.2015.07.020" @default.
• W1424956443 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26387064" @default.
• W1424956443 hasPublicationYear "2015" @default.
• W1424956443 type Work @default.
• W1424956443 sameAs 1424956443 @default.
• W1424956443 citedByCount "27" @default.
• W1424956443 countsByYear W14249564432017 @default.
• W1424956443 countsByYear W14249564432018 @default.
• W1424956443 countsByYear W14249564432019 @default.
• W1424956443 countsByYear W14249564432020 @default.
• W1424956443 countsByYear W14249564432021 @default.
• W1424956443 countsByYear W14249564432022 @default.
• W1424956443 countsByYear W14249564432023 @default.
• W1424956443 crossrefType "journal-article" @default.
• W1424956443 hasAuthorship W1424956443A5013737084 @default.
• W1424956443 hasAuthorship W1424956443A5017288257 @default.
• W1424956443 hasAuthorship W1424956443A5032788800 @default.
• W1424956443 hasAuthorship W1424956443A5040170945 @default.
• W1424956443 hasAuthorship W1424956443A5041265388 @default.
• W1424956443 hasAuthorship W1424956443A5052266233 @default.
• W1424956443 hasAuthorship W1424956443A5069628333 @default.
• W1424956443 hasConcept C104317684 @default.
• W1424956443 hasConcept C126322002 @default.
• W1424956443 hasConcept C141071460 @default.
• W1424956443 hasConcept C179755657 @default.
• W1424956443 hasConcept C2776685102 @default.
• W1424956443 hasConcept C2776933286 @default.
• W1424956443 hasConcept C2777058267 @default.
• W1424956443 hasConcept C2778384902 @default.
• W1424956443 hasConcept C501593827 @default.
• W1424956443 hasConcept C547475151 @default.
• W1424956443 hasConcept C55493867 @default.
• W1424956443 hasConcept C71924100 @default.
• W1424956443 hasConcept C86803240 @default.
• W1424956443 hasConcept C89423630 @default.
• W1424956443 hasConcept C90924648 @default.
• W1424956443 hasConceptScore W1424956443C104317684 @default.
• W1424956443 hasConceptScore W1424956443C126322002 @default.
• W1424956443 hasConceptScore W1424956443C141071460 @default.
• W1424956443 hasConceptScore W1424956443C179755657 @default.
• W1424956443 hasConceptScore W1424956443C2776685102 @default.
• W1424956443 hasConceptScore W1424956443C2776933286 @default.
• W1424956443 hasConceptScore W1424956443C2777058267 @default.
• W1424956443 hasConceptScore W1424956443C2778384902 @default.
• W1424956443 hasConceptScore W1424956443C501593827 @default.
• W1424956443 hasConceptScore W1424956443C547475151 @default.
• W1424956443 hasConceptScore W1424956443C55493867 @default.
• W1424956443 hasConceptScore W1424956443C71924100 @default.
• W1424956443 hasConceptScore W1424956443C86803240 @default.
• W1424956443 hasConceptScore W1424956443C89423630 @default.
• W1424956443 hasConceptScore W1424956443C90924648 @default.
• W1424956443 hasIssue "6" @default.
• W1424956443 hasLocation W14249564431 @default.
• W1424956443 hasLocation W14249564432 @default.
• W1424956443 hasOpenAccess W1424956443 @default.
• W1424956443 hasPrimaryLocation W14249564431 @default.
• W1424956443 hasRelatedWork W1993065586 @default.
• W1424956443 hasRelatedWork W2367973479 @default.
• W1424956443 hasRelatedWork W2386834719 @default.
• W1424956443 hasRelatedWork W2520430333 @default.
• W1424956443 hasRelatedWork W2963257790 @default.
• W1424956443 hasRelatedWork W2989408478 @default.
• W1424956443 hasRelatedWork W2991574077 @default.
• W1424956443 hasRelatedWork W4284710444 @default.

• next